Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • byou678
    Member
    • Aug 2011
    • 52

    #1

    How to check HCV genomic sequences between Two samples is different or not?

    I am looking to determine if the Hepatitis C Virus genomic sequences (variant population structure) between two samples is different to a statistically significant degree.

    If the nucleotide substitution or error rate is 1 in 1000 nucleotides and my target is 1665 nucleotides in length, could i determine a difference in the two populations by sampling 100 clones from each population using traditional sanger sequencing ?
    or would we need to use Nex Gen Sequencing ?
    If we need to NGS, the what depth of coverage would we need to have sufficient power to determine a difference ?

    I really appreciate any response!!
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    A 1665 bp sequence needs 2, maybe 3 sanger sequencing primers to cover completely.

    200 samples, 3 sequencing reactions each, a pretty modest project. You use a multi-channel pipet, you set up two plates of PCR reactions, and send all that out with your three sanger primers.

    200 samples on an Illumina, you only want 1500 reads per sample to get enough coverage, maybe less. (if the reads are distributed equally, that can be tricky with a small PCR product). Every one of those 200 libraries needs to be prepped separately, so it can have its own barcodes.

    You could try pooling the 100 from one population all together, but I'm not sure I would trust that you would be able to tell the difference between a SNV found in a small % of your population and a PCR artifact.

    A typical Illumina run produces a billion reads per flow cell at least. So you need only a tiny bit of real estate on a flow cell.

    Personally, I think Illumina might be overkill. Sanger sequencing is pretty feasible for a few hundred samples across such a small region.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...